Description
An inhibitor of PCNA; binds to PCNA trimers (Kd = 0.41 µM) and reduces the level of chromatin-associated PCNA in PC3 cells; preferentially inhibits growth of a variety of human and mouse cancer cell lines (IC50s = 0.05-0.3 µM) over non-transformed cells (IC50s = 0.99-2 µM); reduces tumor growth in an LNCaP prostate cancer mouse xenograft model at 10 mg/kg administered five days per week for two weeks
Formal name: 3-methyl-2-[(1-hydroxy-2-naphthalenyl)methylene]hydrazide-2-thiophenecarboxylic acid
Synonyms:
Molecular weight: 310.4
CAS: 444930-42-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Cycle|G2/S||Research Area|Epigenetics, Transcription, & Translation|RNA, DNA, & Protein Synthesis